TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00782171

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SLActive dental implant
Description: Straumann® SLActive implants will be placed. Implants in Arm 1 will be restored with a temporary restoration on the day of surgery.~Implants in Arm 2 will receive healing caps immediately after surgery and a provisional restoration will be placed between day 28 to day 34 post-surgery.~In both arms, the final restoration will be placed between 140 and 160 days (20 to 23 weeks) post-surgery.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SLActive dental implant
Description: Straumann® SLActive implants will be placed. Implants in Arm 1 will be restored with a temporary restoration on the day of surgery.~Implants in Arm 2 will receive healing caps immediately after surgery and a provisional restoration will be placed between day 28 to day 34 post-surgery.~In both arms, the final restoration will be placed between 140 and 160 days (20 to 23 weeks) post-surgery.
Study: NCT00967525

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cord blood infusion
Description: Receive two cord blood units. One administered by intraosseous infusion and the other by intravenous infusion. The second unit is being given as a safeguard, but will also allow the researchers to directly compare engraftment between intravenously and intraosseously infused cord blood units.
Study: NCT02042885

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPB-111001
Study: NCT04369118

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional follow-up
Description: Patients in this group benefit from conventional post-operative follow-up

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional follow-up
Description: Patients in this group benefit from conventional post-operative follow-up

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conventional follow-up+chest wall restriction belt
Description: Patients in this group benefit from conventional post-operative follow-up. The patient wear the selective chest wall restriction belt from Day 2 (after surgery) until he ceases to need it.
Study: NCT03760757

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ESPO-572®
Description: ESPO-572® is the same as PCSO-524®, except it has krill oil added to it.
Study: NCT02042885

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPB-111001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPB-111001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPB-111001
Study: NCT00233103

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sertraline
Description: Sertraline arm

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT01411111

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin 10 mg
Description: days 1-14

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin 10 mg
Description: days 1-14

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GSK2190915 30mg
Description: 1x30mg tablet, days 8-14

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GSK2190915 100mg
Description: 1x100mg tablet, days 8-14
Study: NCT03156673

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bronchial basal cells
Description: Patients will receive of clinical grade bronchial basal cells (BBCs) with a dosage of 10\^6 (1 million) cells/Kg/person via fiberoptic bronchoscopy after fully lavage of the localized lesions.
Study: NCT00667004

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ecabet ophthalmic solution
Description: sterile ophthalmic solution

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: sterile ophthalmic solution
Study: NCT03760757

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PCSO-524®
Description: PCSO-524® (Lyprinol®/Omega XL®) is a nutritional supplement containing a patented extract of highly condensed form of stabilized marine lipids from the New Zealand green lipped mussel (Perna canaliculus) that is combined with olive oil and vitamin E. This marine oil lipid and omega-3 polyunsaturated fatty acid (PUFA) blend is a diverse mixture of sterol esters, sterols, polar lipids, triglycerides, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (split between the triacylglycerol and polar lipid classes), and free fatty acids.
Study: NCT01575938

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIV prevention intervention
Description: The 6-session HIV prevention intervention curriculum, LifeSkills, incorporates interactive activities, in-depth discussions, videos, games, and role-plays to help young transgender women develop, practice, and integrate new skills into real-life situations. Activities address each aspect our theoretical framework (information, motivation, behavior), including experiences that may pre-dispose young transgender women to HIV/STI risk. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet and Nutrition
Description: The comparison condition is a 6-session group-based and manualized health promotion intervention. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.
Study: NCT03905369

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Decision aid and SDM booster
Description: The investigators develop the decision aid and SDM booster. The scope of the investigators of decision making combines the clinical and patient perspective. The decision aids are developed for patients with TC either newly diagnosed or patients with advanced disease, presently in the follow-up at the participating centers, covering the whole treatment trajectory of these patients (Figure 4). Three treatment decisions are considered: 1) the extent of thyroid resection, 2) the use of RAI, and 3) the initiation of TKIs.The SDM-booster is developed alongside the decision aids, as the SDM-booster (or values clarification exercise) is often a component developed together with a decision aid. The SDM-booster aims to shape patients' values regarding aspects of the decision and ensuing treatment preferences.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Deliberation training
Description: The investigators develop the deliberation training. It makes physicians more aware and responsive to patients' values. The communication training for physicians will consist of 1) an e-learning SDM-training lasting 40 minutes and, 2) an individual values deliberation training lasting 2 hours.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deliberation training
Description: The investigators develop the deliberation training. It makes physicians more aware and responsive to patients' values. The communication training for physicians will consist of 1) an e-learning SDM-training lasting 40 minutes and, 2) an individual values deliberation training lasting 2 hours.
Study: NCT03472664

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low carbohydrate/high fat diet
Description: Modified Mediterranean-Ketogenic Diet is a low carbohydrate/high fat diet.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low fat/high carbohydrate diet
Description: American Heart Association Diet is a low fat/high carbohydrate diet.
Study: NCT02108717

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote CT reading using the iPhone
Study: NCT00642252

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride
Description: Over-the-counter level of fluoride (226 ppm) in a fluoride mouthrinse; FDA considers fluoride in a rinse formulation as a 'drug'; dosage is 10 mL per treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluoride
Description: Over-the-counter level of fluoride (226 ppm) plus calcium (30 ppm) in a fluoride mouthrinse; FDA considers fluoride in a rinse formulation as a 'drug'; dosage is 10 mL per treatment.
Study: NCT03461731

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Control
Description: laser beam only
Study: NCT02108717

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote CT reading using the iPhone

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CT reading using LCD monitor
Study: NCT00894049

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: reduced intensity conditionings
Description: comparison of non myeloablative (Flu-TBI) and reduced intensity (FLU-BU-ATG)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: reduced intensity conditionings
Description: comparison of non myeloablative (Flu-TBI) and reduced intensity (FLU-BU-ATG)
Study: NCT01964703

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rubus occidentalis extract

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rubus occidentalis extract
Study: NCT02108717

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CT reading using LCD monitor
Study: NCT01310179

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Ad/PNP and fludarabine monophosphate
Description: Subjects in the first 3 cohorts will receive 3x10e11 VP for 3 injections and escalating dose levels of F-araAMP (15, 45, and 75 mg/m2 in each sequential cohort) daily for 3 days. The fourth cohort will receive 3x10e12 for 3 injections and 75 mg/m2 fludarabine daily for 3 days.
Study: NCT03373890

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Short Burst Interval Locomotor Treadmill Training (SBLTT)
Description: SBLTT consists of interval training consisting of short-bursts (30 seconds) of vigorous intensity locomotor treadmill training (LTT) alternating with low to moderate intensity LTT.,

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Short Burst Interval Locomotor Treadmill Training (SBLTT)
Description: SBLTT consists of interval training consisting of short-bursts (30 seconds) of vigorous intensity locomotor treadmill training (LTT) alternating with low to moderate intensity LTT.,
Study: NCT01874275

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: VECTTOR
Description: The VT-200, or VECTTOR system, delivers electrical stimulation via electrodes on the acupuncture points of a patient's feet/legs and hands/arms to provide symptomatic relief of chronic intractable pain and/or management of post-surgical pain.~Once these electrodes are placed, the machine determines the appropriate choice of stimulation by automatically measuring body temperatures through the use of thermistors placed on the fingers during a testing sequence.
Study: NCT04501666

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nemolizumab 30 mg
Description: Participants received either 30 mg or 60 mg dose of nemolizumab as SC injection.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants received matching placebo as SC injection.
Study: NCT02610322

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: usual diet
Description: Participants who are assigned to the usual diet group (control group) will receive a 5\~10 min conventional lifestyle education on MetS by a research staff in which the general recommendation for macronutrient composition of the control diet will be 50-60% of energy as carbohydrate, 15-20% of energy as protein, and \<30% of energy as total fat.
Study: NCT03846037

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive exercise on the vibratory platform
Description: Unipodal support over the non-dominant lower limb with the contralateral limb in a knee flexion near 90ºon the vibratory platform

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Proprioceptive exercise on the ground (stable surface)
Description: Unipodal support over the non-dominant lower limb with the contralateral limb in a knee flexion near 90ºon the ground
Study: NCT02054351

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMAB027
Description: Stage 1 (Intrapatient dose escalation): The starting dose is set to 1 mg/m2, followed by 10 mg/m2, 30 mg/m2 and 100 mg/m2 Stage 2 (Interpatient dose escalation): 4 dose level 100 mg/m2, 300 mg/m2, 600 mg/m2, 1000 mg/m2 Extension period: 4 dose level 100 mg/m2, 300 mg/m2, 600 mg/m2, 1000 mg/m2
Study: NCT06179797

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: remote ischemic conditioning
Description: suprasystolic BP sequential compression of both arms with blood pressure cuffs for 5 min on/off for 4 cycles.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: remote ischemic conditioning
Description: suprasystolic BP sequential compression of both arms with blood pressure cuffs for 5 min on/off for 4 cycles.
Study: NCT01874275

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VECTTOR
Description: The VT-200, or VECTTOR system, delivers electrical stimulation via electrodes on the acupuncture points of a patient's feet/legs and hands/arms to provide symptomatic relief of chronic intractable pain and/or management of post-surgical pain.~Once these electrodes are placed, the machine determines the appropriate choice of stimulation by automatically measuring body temperatures through the use of thermistors placed on the fingers during a testing sequence.
Study: NCT01476189

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental paracetamol formulation
Description: experimental

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Marketed paracetamol
Description: Marketed paracetamol

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Higher dose marketed paracetamol
Description: Higher dose marketed paracetamol
Study: NCT01588262

Intervention type: OTHER
Group type: OTHER
Intervention: Stressmanagement
Description: Individual stepped-care approach stressmanagement by specially trained counsellor
Study: NCT04545164

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CAD4TB
Description: CAD4TB is a Computer Aided Diagnosis (CAD) image processing algorithm that can aid interpretation of Chest X-ray images to accurately detect tuberculosis.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: CAD4TB
Description: CAD4TB is a Computer Aided Diagnosis (CAD) image processing algorithm that can aid interpretation of Chest X-ray images to accurately detect tuberculosis.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: FujiLAM
Description: Fujifilm SILVAMP TB LAM is a high sensitivity test for mycobacterial lipoarabinomannan (LAM) in urine samples.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: FujiLAM
Description: Fujifilm SILVAMP TB LAM is a high sensitivity test for mycobacterial lipoarabinomannan (LAM) in urine samples.
Study: NCT05797532

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: breastfeeding
Description: The NIPS (Neonatal Infant Pain Scale) pain score, heart rate and oxygen saturation of the newborn were recorded by the researcher in the study group, 2 minutes before the heel lance, 10 seconds during the heel lance, and 2 minutes after the heel lance was completed.~In order to determine the crying time of newborns in all three study groups, the voice recorder and stopwatch were turned on two minutes before and 2 minutes after the heel lance.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: skin to skin contact
Description: The NIPS (Neonatal Infant Pain Scale) pain score, heart rate and oxygen saturation of the newborn were recorded by the researcher in the study group, 2 minutes before the heel lance, 10 seconds during the heel lance, and 2 minutes after the heel lance was completed.~In order to determine the crying time of newborns in all three study groups, the voice recorder and stopwatch were turned on two minutes before and 2 minutes after the heel lance.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: swaddling and holding
Description: The NIPS (Neonatal Infant Pain Scale) pain score, heart rate and oxygen saturation of the newborn were recorded by the researcher in the study group, 2 minutes before the heel lance, 10 seconds during the heel lance, and 2 minutes after the heel lance was completed.~In order to determine the crying time of newborns in all three study groups, the voice recorder and stopwatch were turned on two minutes before and 2 minutes after the heel lance.
Study: NCT02504112

Intervention type: OTHER
Intervention: there is no intervention
Study: NCT01789138

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Situated Optimal Adherence Intervention
Description: Situated Optimal Adherence Intervention consists of 3 individual sessions (during consecutive medication pick-up visits to the clinic) -- patient-centered, non-judgmental, Motivational Interviewing- and theory-based, semi-structured, brief, candid conversations with a trained clinical care nurse using the Next Step Counseling approach. The intervention targets: accurate information about ART (mechanisms of HIV and antiretrovirals) and the development of mental imagery around it; promotion of perceived sense of ease and efficacy in working the ART regimen into the context of one's daily life and circumstances that may challenge drug use persistence; identification and refinement of skills that promote ease of adhering to one's ART regimen across the diverse and challenging contexts.
Study: NCT02105493

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 500 microgram of Nitroglycerin
Description: 500 microgram of Nitroglycerin (in 5 mL saline) given intra-arterially through the sheath at the end of transradial procedure

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline 5 mL
Description: Saline 5 mL given intra-arterially through the sheath at the end of transradial procedure
Study: NCT03407495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IOP Injection (MPB-1523)
Description: one dose, once IV injection at Day 1
Study: NCT02230761

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XOPH5 Ointment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT03586323

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: superior laryngeal nerve block with lidocaine
Description: SLNB was performed with 4 ml of 1.5% lidocaine below the thyroid membrane

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: superior laryngeal nerve block with lidocaine
Description: SLNB was performed with 4 ml of 1.5% lidocaine below the thyroid membrane
Study: NCT04257175

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T CD19
Description: The CAR-T infusion will be given in IV infusion. The target dose is 1 X 106 positive CAR / kg T cells (range: 0.5-1.5X 106 CAR / kg positive T cells).
Study: NCT03078790

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iPad
Description: a 10 minute electronic guided deep breathing module offered via an iPad
Study: NCT02001415

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spectacles
Description: Normal spectacle lenses were used to correct myopia as the control group.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myovision
Description: Myovision is a kind of specially designed spectacle glasses that could control the peripheral refraction of myopia patients. It is commercially available.
Study: NCT06179797

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: remote ischemic conditioning
Description: suprasystolic BP sequential compression of both arms with blood pressure cuffs for 5 min on/off for 4 cycles.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: remote ischemic conditioning
Description: suprasystolic BP sequential compression of both arms with blood pressure cuffs for 5 min on/off for 4 cycles.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: remote ischemic conditioning
Description: suprasystolic BP sequential compression of both arms with blood pressure cuffs for 5 min on/off for 4 cycles.
Study: NCT00941473

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinilone (kenalog)
Description: Epidural steroid injection of 80mg of Triamcinilone.
Study: NCT02701439

Intervention type: DEVICE
Intervention: Small membrane filtration
Description: Following the Ugandan National Tuberculosis and Leprosy Programme (NTLP) guidelines, all enrolled TB suspects will undergo the following standardized evaluation:~* Abbreviated demographic and clinical evaluation~* TB history and evaluation~* Obtain three sputum samples - one early morning sample and two spot samples~* HIV testing (and CD4 if positive)~* Chest radiograph~* Small membrane filtration intervention will be administered to both arms

Intervention type: DEVICE
Intervention: Small membrane filtration
Description: Following the Ugandan National Tuberculosis and Leprosy Programme (NTLP) guidelines, all enrolled TB suspects will undergo the following standardized evaluation:~* Abbreviated demographic and clinical evaluation~* TB history and evaluation~* Obtain three sputum samples - one early morning sample and two spot samples~* HIV testing (and CD4 if positive)~* Chest radiograph~* Small membrane filtration intervention will be administered to both arms
Study: NCT03176329

Intervention type: OTHER
Group type: OTHER
Intervention: Nursing 1 : INTELLIVENT-ASV

Intervention type: OTHER
Group type: OTHER
Intervention: Nursing 2 : INTELLIVENT-ASV

Intervention type: OTHER
Group type: OTHER
Intervention: Nursing 1 : Conventional mode

Intervention type: OTHER
Group type: OTHER
Intervention: Nursing 2 : Conventional mode
Study: NCT01879150

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cyclaplex bone anchor
Description: Device implantation